Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records

BMC Infectious Diseases

Eric J Velazquez³  Sylvester Kimaiyo¹  Edwin Sang¹  Thomas L Holland⁴  Alfred Keter¹  Joseph W Hogan²  Gerald S Bloomfield³ 

[1]Department of Medicine, School of Medicine, College of Health Sciences, Moi University, PO Box 4606, Eldoret 30100, Kenya

[2]Academic Model Providing Access to Healthcare, PO Box 4606, Eldoret 30100, Kenya

[3]Duke Global Health Institute, Trent Hall, 310 Trent Drive, Durham, NC 27710, USA

[4]Division of Infectious Diseases & International Health, Department of Medicine, Duke University School of Medicine, DUMC 102359, Durham, NC 27710, USA

关键词: sub-Saharan Africa;    Global health;    Mortality;    HIV;    Blood pressure;   

Others  :  1127723
DOI  :  10.1186/1471-2334-14-284

 received in 2014-01-18, accepted in 2014-05-14,  发布年份 2014

【 摘 要 】

Background

Mortality among people with human immunodeficiency virus (HIV) infection is increasingly due to non-communicable causes. This has been observed mostly in developed countries and the routine care of HIV infected individuals has now expanded to include attention to cardiovascular risk factors. Cardiovascular risk factors such as high blood pressure are often overlooked among HIV seropositive (+) individuals in sub-Saharan Africa. We aimed to determine the effect of blood pressure on mortality among HIV+ adults in Kenya.

Methods

We performed a retrospective analysis of electronic medical records of a large HIV treatment program in western Kenya between 2005 and 2010. All included individuals were HIV+. We excluded participants with AIDS, who were <16 or >80 years old, or had data out of acceptable ranges. Missing data for key covariates was addressed by inverse probability weighting. Primary outcome measures were crude mortality rate and mortality hazard ratio (HR) using Cox proportional hazards models adjusted for potential confounders including HIV stage.

Results

There were 49,475 (74% women) HIV+ individuals who met inclusion and exclusion criteria. Mortality rates for men and women were 3.8 and 1.8/100 person-years, respectively, and highest among those with the lowest blood pressures. Low blood pressure was associated with the highest mortality incidence rate (IR) (systolic <100 mmHg IR 5.2 [4.8-5.7]; diastolic <60 mmHg IR 9.2 [8.3-10.2]). Mortality rate among men with high systolic blood pressure without advanced HIV (3.0, 95% CI: 1.6-5.5) was higher than men with normal systolic blood pressure (1.1, 95% CI: 0.7-1.7). In weighted proportional hazards regression models, men without advanced HIV disease and systolic blood pressure ≥140 mmHg carried a higher mortality risk than normotensive men (HR: 2.39, 95% CI: 0.94-6.08).

Conclusions

Although there has been little attention paid to high blood pressure among HIV+ Africans, we show that blood pressure level among HIV+ patients in Kenya is related to mortality. Low blood pressure carries the highest mortality risk. High systolic blood pressure is associated with mortality among patients whose disease is not advanced. Further investigation is needed into the cause of death for such patients.

【 授权许可】

   
2014 Bloomfield et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Antiretroviral Therapy Cohort Collaboration: Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010, 50(10):1387-1396.
• [2]Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA: Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis 2014, 58(1):e1-34.
• [3]Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A: HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol 2013, 61(5):511-523.
• [4]Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY: The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS 2012, 26(9):1115-1120.
• [5]Triant VA, Lee H, Hadigan C, Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92(7):2506-2512.
• [6]Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349(21):1993-2003.
• [7]Triant VA: HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis 2012, 205(Suppl 3):S355-361.
• [8]Joint United Nations Programme on HIV/AIDS (UNAIDS): World AIDS Day Report. Geneva: UNAIDS; 2012.
• [9]Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J, Were W, Kaharuza F, Alexander LN, Downing R, Mermim J: Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2011, 58(3):289-296.
• [10]Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N: Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE 2011, 6(12):e28691.
• [11]Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration: Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013, 10(4):e1001418.
• [12]Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, Kimaiyo S: Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS ONE 2011, 6(7):e22288.
• [13]Rabkin M, El-Sadr WM: Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Hlth 2011, 6(3):247-256.
• [14]Einterz RM, Kimaiyo S, Mengech HNK, Khwa-Otsyula BO, Esamai F, Quigley F, Mamlin JJ: Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 2007, 82(8):812-818.
• [15]Yiannoutsos CT, An M-W, Frangakis CE, Musick BS, Braitstein P, Wools-Kaloustian K, Ochieng D, Martin JN, Bacon MC, Ochieng V, Kimaiyo S: Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 2008, 3(12):e3843.
• [16]World Health Organization: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. France: World Health Organization Press; 2007.
• [17]Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, (CDC) CfDCaP: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep 2008, 57(RR-10):1-12.
• [18]Robins J, Rotnitzky A, Zhao L: Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assocv 1994, 89(427):846-866.
• [19]Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PWF, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH: State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation 2008, 118(2):198-210.
• [20]Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ: Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg 2011, 105(11):644-649.
• [21]Meya DB, Katabira E, Otim M, Ronald A, Colebunders R, Njama D, Mayanja-Kizza H, Whalen CC, Sande M: Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci 2007, 7(2):101-107.
• [22]Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD: Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008, 22(15):2035-2038.
• [23]Compostella C, Compostella L, D'Elia R: The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008, 18(1):6-12.
• [24]Okeahialam BN, Sani MU: Heart disease in HIV/AIDS. How much is due to cachexia? Afr J Med Med Sci 2006, 35(Suppl):99-102.
• [25]Mateen FJ, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP, Mills EJ: Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens 2013, 31(7):1372-1378. discussion 1378
• [26]Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Study MAC: Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005, 19(9):953-960.
• [27]Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF: Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010, 3(1):132-139.
• [28]Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD: Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004, 109(3):316-319.
• [29]Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard P-M, Costagliola D, Cohen A, Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators: Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J 2011, 32(1):41-50.
• [30]Nyabera R, Yonga G, Mwangemi F, Bukachi F: Evaluation of a project integrating cardiovascular care into HIV programmes. Cardiovasc J Afr 2011, 22(3):S17.
• [31]Chillo P, Bakari M, Lwakatare J: Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania. Cardiovasc J Afr 2012, 23(2):90-97.
• [32]Schwartz T, Girgis M, Steen TW, Sjaasatd I: HIV as a risk factor for cardiac disease in Botswana: a cross-sectional study. Cardiovasc J Afr 2011, 22(3):S23.
• [33]Sani MU, Muhammad S, Okeahialam BN: Effects of HAART on cardiovascular risk profile of HIV/AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Cardiovasc J Afr 2011, 22(3):S22.
• [34]Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, Levitt NS, Crowther NJ, Nyirenda M, Njelekela M, Ramaiya K, Nyan O, Adewole OO, Anastos K, Azzoni L, Boom WH, Compostella C, Dave JA, Dawood H, Erikstrup C, Fourie CM, Friis H, Kruger A, Idoko JA, Longenecker CT, Mbondi S, Mukaya JE, Mutimura E, Ndhlovu CE: Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol 2013, 42:1754-1771.
• [35]Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, Konde-Lule J, Okech-Ojony J, Rubaale T: Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health 2010, 2:45-52.
• [36]Oti SO, Mutua M, Mgomella GS, Egondi T, Ezeh A, Kyobutungi C: HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis. BMC Public Health 2013, 13:588. BioMed Central Full Text
• [37]Byass P, Calvert C, Miiro-Nakiyingi J, Lutalo T, Michael D, Crampin A, Gregson S, Takaruza A, Robertson L, Herbst K, Todd J, Zaba B: InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Act 2013, 6:22448.